Basel, 20th of May 2011

Copperbelt increases capital

(ISIN: CH0109600491; WKN: A0Q9UF)

The Board of Copperbelt AG announces the successful completion of a capital increase of 2 million shares at a price of CHF 0.30 per share (CHF 0.02 nominal value + CHF 0.28 Agio). CHF 600,000 accrue to the company. With a nominal value of the shares of CHF 0.02 the share capital will thus increase by CHF 40,000, of which CHF 560,000 go to free reserves. The new share capital amounts to CHF 1.380.000. The number of shares increases from 67 million to 69 million. The registration of the capital increase in the commercial register of Canton Basel-City took place on 12th of May 2011.


The capital increase from authorized capital was carried out under exclusion of subscription rights and was decided on 2nd of May 2011. It was placed with financial investors. The capital increase will serve for further development of the copper-gold project of the subsidiary Dostyk Ltd. in Kazakhstan.


For the Board,
Peter Goeggel

This document was prepared by Copperbelt AG. The opinions stated herein are those of Copperbelt AG at the time of publication and are subject to change at any time. The document is only for the purpose of information and use by its recipient. It is neither an offer nor an invitation to purchase or sell Copperbelt AG shares. A reference to the performance of the past shall not be understood as an indication of future developments. The information and analysis contained in this publication have been compiled from sources that are deemed to be reliable. However, Copperbelt AG gives no guarantee with regard to their reliability and completeness and rejects any claim for damages that may be the result of use of this information. These press releases / Research/ analysis / content of the website may not be accessed directly or indirectly in the U.S., Canada, Japan and Australia, to U.S. citizens or persons resident in the named countries, yet brought in their territory transmitted, or distributed. Persons into whose possession this document comes should inform themselves about possible legal restrictions on the dissemination of such research and comply with them. Any failure to comply with this restriction may constitute a violation of U.S., Japanese, Australian or Canadian securities laws or the laws of another jurisdiction.